Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
- PMID: 38765788
- PMCID: PMC11102100
- DOI: 10.2147/PGPM.S457805
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Abstract
Purpose: To investigate the CYP2C19 genotype distribution and allelic frequency among the Zhuang and Han schizophrenic populations in Guangxi, examine the correlation between CYP2C19 genetic variants and standardized blood levels of Valproic Acid (VPA) in schizophrenic patients, and evaluate the effects of age, gender, and Body Mass Index (BMI) on standardized VPA blood concentrations.
Patients and methods: Between February and December 2022, 192 Zhuang and Han schizophrenia patients treated with VPA were studied. Steady-state VPA concentrations were determined using homogeneous enzyme immunoassays, and CYP2C19 *1, *2, and *3 loci via q-PCR. CYP2C19 genotype distributions between Zhuang and Han groups in Nanning were compared using chi-square tests and contrasted with other ethnicities. Non-parametric tests analyzed VPA variations, identifying critical factors through multivariate stepwise regression.
Results: The study identified five CYP2C19 genotypes at the *2 and *3 loci, with the *3/*3 genotype absent in both cohorts. The CYP2C19 distribution in Guangxi Zhuang and Han mirrors, yet diverges significantly from Hui and Kazakh groups. Among 192 subjects, VPA blood levels remained consistent across metabolic types and ages 18-60 but varied significantly by gender. Multivariate analysis revealed gender and BMI as significant factors, overshadowing CYP2C19 genotype and age.
Conclusion: In Guangxi, CYP2C19 genetic variants in Zhuang and Han schizophrenia patients demonstrate statistically indistinguishable allelic and metabolic distributions. Gender and BMI can influence standardized VPA blood concentrations in schizophrenia patients. However, in our study cohort, the CYP2C19 genotype and age are not the primary determinants of standardized VPA blood levels.
Keywords: CYP2C19 gene; Han Chinese; Zhuang Chinese; blood drug concentration; valproic acid.
© 2024 Teng et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Variable frequencies of apolipoprotein E genotypes and its effect on serum lipids in the Guangxi Zhuang and Han children.Int J Mol Sci. 2011;12(9):5604-15. doi: 10.3390/ijms12095604. Epub 2011 Aug 31. Int J Mol Sci. 2011. PMID: 22016612 Free PMC article.
-
Effect of CYP2C19 polymorphisms on serum valproic level acid in Chinese Han patients with schizophrenia.Sci Rep. 2021 Nov 30;11(1):23150. doi: 10.1038/s41598-021-02628-x. Sci Rep. 2021. PMID: 34848811 Free PMC article.
-
Apolipoprotein E gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations.Exp Biol Med (Maywood). 2008 Apr;233(4):409-18. doi: 10.3181/0709-RM-254. Exp Biol Med (Maywood). 2008. PMID: 18367629
-
Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations.J Investig Med. 2008 Aug;56(6):847-57. doi: 10.2310/JIM.0b013e3181820832. J Investig Med. 2008. PMID: 18667902
-
Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.Eur J Clin Pharmacol. 2020 Aug;76(8):1053-1058. doi: 10.1007/s00228-020-02872-6. Epub 2020 May 8. Eur J Clin Pharmacol. 2020. PMID: 32385545
References
LinkOut - more resources
Full Text Sources